GlassScriptPhysician profile
Fakhar Ahmad
NPI 1295781094
$981.60
in general payments reported to CMS, 2019-2025
17 companies · $89.07 in 2025
The $89.07 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $33.07 · 2021: $77.10 · 2022: $103 · 2023: $267 · 2024: $274 · 2025: $89.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $239.69 | 2019-2024 | Xarelto |
| Pfizer INC. | $170.75 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $111.63 | 2023-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $75.82 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $54.07 | 2021-2022 | |
| Gilead Sciences, INC. | $51.83 | 2023-2024 | Veklury |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.17 | 2022-2024 | Jardiance |
| Mylan Specialty L.P. | $45.55 | 2023-2024 | Yupelri |
| Inari Medical, INC. | $36.94 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Viatris Specialty LLC | $26.75 | 2025 | Yupelri |
| Bioxcel Therapeutics, INC. | $23.75 | 2023 | Igalmi |
| Portola Pharmaceuticals, LLC | $22.53 | 2019 | |
| Abbott Laboratories | $16.12 | 2023 | Amplatzer Amulet |
| Alexion Pharmaceuticals, INC. | $15.11 | 2025 | Ultomiris |
| Astrazeneca Pharmaceuticals LP | $15.04 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $14.97 | 2023 | Inpefa |
| Sunovion Pharmaceuticals INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fakhar Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.